Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ALLO
Stock Latest News
The Fly
Allogene Therapeutics expands Phase 2 ALPHA3 trial to South Korea, Australia
16d ago
ALLO
Premium
The Fly
Allogene Therapeutics price target lowered to $11 from $12 at H.C. Wainwright
21d ago
ALLO
Premium
The Fly
Allogene Therapeutics upgraded to Neutral from Underweight at JPMorgan
21d ago
ALLO
Premium
Company Announcements
Allogene Therapeutics Prices Large Common Stock Offering
22d ago
8K
ALLO
Premium
The Fly
Allogene Therapeutics price target raised to $10 from $6 at Jefferies
22d ago
ALLO
Premium
The Fly
Unusually active option classes on open April 15th
22d ago
AEO
ALLO
Premium
The Fly
Allogene Therapeutics 87.5M share Spot Secondary priced at $2.00
23d ago
ALLO
Premium
The Fly
Allogene Therapeutics price target raised to $3.85 from $1.60 at Bernstein
23d ago
ALLO
Premium
The Fly
Allogene Therapeutics price target raised to $9 from $7 at Baird
23d ago
ALLO
Premium
The Fly
Allogene Therapeutics price target raised to $12 from $8 at H.C. Wainwright
23d ago
ALLO
Premium
The Fly
Allogene Therapeutics price target raised to $8 from $5 at Citizens
23d ago
ALLO
Premium
The Fly
Cellectis highlights Allogene ALPHA3 trial data, potential milestone payments
24d ago
ALLO
CLLS
Premium
Company Announcements
Allogene Therapeutics Launches New Underwritten Common Stock Offering
24d ago
8K
ALLO
Premium
The Fly
Allogene Therapeutics announces $175M common stock offering
24d ago
ALLO
Premium
The Fly
Midday Fly By: Goldman reports Q1 beat, Baker Hughes to sell Waygate
24d ago
GS
BBY
Premium
The Fly
Morning Movers: Leggett & Platt gains, Somnigroup lower after $2.5B deal
24d ago
GS
BBY
Premium
Ratings
Allogene Therapeutics: Strong ALPHA3 Futility Data and Favorable Safety Profile Support Buy Rating and Blockbuster Potential for Cema-cel in LBCL
24d ago
ALLO
Premium
Company Announcements
Allogene Highlights Positive Interim ALPHA3 CAR T Data
24d ago
8K
ALLO
Premium
The Fly
Natera highlights Allogene Therapeutics’ analysis from ALPHA3 trial
24d ago
ALLO
NTRA
Premium
The Fly
Allogene Therapeutics data from ALPHA3 trial a ‘home run,’ says TD Cowen
24d ago
ALLO
Premium
The Fly
Allogene Therapeutics reports data from ALPHA3 trial
24d ago
ALLO
Premium
Company Announcements
Allogene Therapeutics Faces Trial Setback as ALLO-647 Halt Raises Lymphodepletion and Regulatory Timeline Risks
2M ago
ALLO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
